Pharvaris N.V.
PHVS
$14.00
$0.282.04%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 11.14% | 9.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.35% | 12.60% | |||
| Operating Income | -15.35% | -12.60% | |||
| Income Before Tax | 21.64% | -42.85% | |||
| Income Tax Expenses | 422.09% | 232.89% | |||
| Earnings from Continuing Operations | 19.19% | -43.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 19.19% | -43.30% | |||
| EBIT | -15.35% | -12.60% | |||
| EBITDA | -15.32% | -12.60% | |||
| EPS Basic | 19.57% | -42.95% | |||
| Normalized Basic EPS | 22.01% | -42.50% | |||
| EPS Diluted | 19.57% | -42.95% | |||
| Normalized Diluted EPS | 22.01% | -42.50% | |||
| Average Basic Shares Outstanding | 0.47% | 0.24% | |||
| Average Diluted Shares Outstanding | 0.47% | 0.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||